13F Filings History of GREAT POINT PARTNERS LLC
- Latest 13F filing
- Q2 2026 - 14 Aug 2026
- Latest reported 13F value
- $424,448,729
- Largest 13F holdings
-
VOR ABVX VERA ZURA ALMS SLGL DFTX ANNX ORKA MLTX SGMT CTNM
+8 more
IMMX CLYM AMLX NKTR NGNE LBRX IRD EPRX - Notable people
- Jeffrey R. Jay, David Kroin, Ortav Yehudai, Lillian Nordahl
- Form 13F summary
-
- GREAT POINT PARTNERS LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- GREAT POINT PARTNERS LLC reported 37 equity holdings with a total reported market value of $424,448,729 for Q2 2026. Top reported holdings included VOR, ABVX, VERA, ZURA, and ALMS.
- Manager signature
- Dr. Jeffrey R. Jay, M.D. - Senior Managing Member
- Manager location
- Greenwich, CT
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow GREAT POINT PARTNERS LLC with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q2 2026
Latest value
$424,448,729
Quarter delta
+$16,179,022
Accepted
14 Aug 2026, 16:13
Rows shown
1-25 of 51
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 37 | $424,448,729 | +$147,175,611 | -$177,562,975 | -$30,387,364 | VOR, ABVX, VERA, ZURA, ALMS | 13F-HR | 14 Aug 2026, 16:13 |
| Q1 2026 | 39 | $408,269,707 | +$175,589,440 | -$115,866,560 | +$59,722,880 | APGE, VOR, ZURA, AMLX, NKTR | 13F-HR | 15 May 2026, 16:00 |
| Q4 2025 | 29 | $308,414,328 | +$143,339,046 | -$81,469,179 | +$61,869,867 | APGE, AMLX, ZURA, IRON, RAPT | 13F-HR | 17 Feb 2026, 16:08 |
| Q3 2025 | 28 | $239,520,840 | +$96,939,529 | -$173,164,255 | -$76,224,726 | AMLX, RZLT, NKTR, ZURA, SLNO | 13F-HR | 14 Nov 2025, 11:49 |
| Q2 2025 | 26 | $153,801,796 | +$56,641,300 | -$101,478,949 | -$44,837,649 | IONS, RZLT, AMLX, LEGN, ABVX | 13F-HR | 14 Aug 2025, 16:15 |
| Q1 2025 | 31 | $183,973,769 | +$53,297,480 | -$38,718,197 | +$14,579,283 | CYTK, KALV, EOLS, ABVX, VRDN | 13F-HR | 15 May 2025, 16:10 |
| Q4 2024 | 26 | $212,199,809 | +$41,418,205 | -$102,967,171 | -$61,548,966 | IONS, CYTK, KALV, VRDN, PLRX | 13F-HR | 14 Feb 2025, 16:13 |
| Q3 2024 | 29 | $331,410,559 | +$32,570,018 | -$227,355,322 | -$194,785,304 | NGNE, ABVX, PLRX, EOLS, VRDN | 13F-HR | 13 Nov 2024, 16:16 |
| Q2 2024 | 33 | $522,016,114 | +$170,044,820 | -$249,939,479 | -$79,894,659 | URGN, NGNE, ABVX, MRUS, PLRX | 13F-HR | 14 Aug 2024, 16:38 |
| Q1 2024 | 35 | $641,637,881 | +$222,251,387 | -$293,899,773 | -$71,648,386 | NGNE, ALPN, URGN, ABVX, EOLS | 13F-HR | 15 May 2024, 16:24 |
| Q4 2023 | 34 | $586,726,411 | +$114,195,081 | -$189,141,338 | -$74,946,257 | ALPN, CYTK, URGN, PLRX, RARE | 13F-HR | 14 Feb 2024, 16:07 |
| Q3 2023 | 39 | $531,602,489 | +$165,234,328 | -$92,413,058 | +$72,821,270 | URGN, ALPN, PLRX, PCVX, RARE | 13F-HR | 14 Nov 2023, 16:16 |
| Q2 2023 | 36 | $499,223,928 | +$135,081,465 | -$147,003,304 | -$11,921,839 | ALPN, RARE, PCVX, PLRX, RAPT | 13F-HR | 14 Aug 2023, 16:17 |
| Q1 2023 | 42 | $505,967,073 | +$180,872,324 | -$150,491,950 | +$30,380,374 | PLRX, XENE, ALPN, RARE, RAPT | 13F-HR | 15 May 2023, 16:09 |
| Q4 2022 | 40 | $483,681,723 | +$218,587,663 | -$127,179,273 | +$91,408,390 | PCVX, XENE, RAPT, ALPN, PLRX | 13F-HR | 14 Feb 2023, 16:02 |
| Q3 2022 | 40 | $406,202,118 | +$145,503,060 | -$166,316,107 | -$20,813,047 | XENE, JAZZ, PNT, ALPN, TVTX | 13F-HR | 14 Nov 2022, 16:24 |
| Q2 2022 | 33 | $376,877,275 | +$128,178,692 | -$122,276,262 | +$5,902,430 | XENE, JAZZ, CYTK, TVTX, PCVX | 13F-HR | 15 Aug 2022, 16:25 |
| Q1 2022 | 29 | $413,242,000 | +$137,128,331 | -$158,595,309 | -$21,466,978 | EXEL, XENE, TVTX, BCYC, JAZZ | 13F-HR | 16 May 2022, 16:24 |
| Q4 2021 | 35 | $447,367,000 | +$170,610,787 | -$150,649,986 | +$19,960,801 | ARNA, EXEL, XENE, TVTX, ANAB | 13F-HR | 14 Feb 2022, 11:22 |
| Q3 2021 | 35 | $422,880,000 | +$155,126,905 | -$173,039,983 | -$17,913,078 | EXEL, ARNA, KDMN, BCAB, RCKT | 13F-HR | 15 Nov 2021, 16:36 |
| Q2 2021 | 28 | $447,211,000 | +$139,590,097 | -$146,460,856 | -$6,870,759 | MGNX, RCKT, ARNA, UTHR, PODD | 13F-HR | 16 Aug 2021, 16:33 |
| Q1 2021 | 28 | $483,855,000 | +$164,991,284 | -$240,886,976 | -$75,895,692 | MGNX, RCKT, IOVA, SAGE, XENT | 13F-HR | 17 May 2021, 16:05 |
| Q4 2020 | 31 | $607,037,000 | +$172,475,216 | -$883,745,776 | -$711,270,560 | GWPH, IOVA, SAGE, ACAD, RCKT | 13F-HR | 16 Feb 2021, 16:17 |
| Q3 2020 | 33 | $1,106,166,000 | +$174,494,061 | -$336,217,042 | -$161,722,981 | IOVA, SAGE, ACAD, ARNA, ZYME | 13F-HR | 16 Nov 2020, 16:41 |
| Q2 2020 | 35 | $1,244,184,000 | +$476,455,187 | -$244,347,277 | +$232,107,910 | CNST, IOVA, ZYME, ACAD, SAGE | 13F-HR | 14 Aug 2020, 16:55 |